CD8A and cancer: Effective anti-cancer therapies often exploit the immune system to boost anti-cancer responses by enhancing the inflammatory functions of key immune cells including antigen-presenting dendritic cells (DC) and CD8+ effector T cells (reviewed in [19, 20]).